OLMA (Olema Pharmaceuticals) Forward PE Ratio: 0.00 (As of Jul. 08, 2026)


OLMA Olema Pharmaceuticals inc OLMA
28 GF Score
Price $12.28
! 2 Warning Signs
View Full Analysis

What is Olema Pharmaceuticals Forward PE Ratio?

Olema Pharmaceuticals OLMA -2.93% 28 Forward PE Ratio is 0.00 as of Jul. 08, 2026. GuruFocus rates OLMA with a GF Score™ of 28/100. The stock has 2 warning signs investors should review. Among 354 Biotechnology companies, Olema Pharmaceuticals ranks worse than 282485.59% on this metric.

Olema Pharmaceuticals's Forward PE Ratio for today is 0.00.

Olema Pharmaceuticals's PE Ratio without NRI for today is 0.00.

Olema Pharmaceuticals's PE Ratio (TTM) for today is 0.00.


Olema Pharmaceuticals  (NAS:OLMA) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Olema Pharmaceuticals Forward PE Ratio Related Terms


Olema Pharmaceuticals Forward PE Ratio Historical Data

* Premium members only.

The historical data trend for Olema Pharmaceuticals's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Olema Pharmaceuticals Forward PE Ratio Chart

Olema Pharmaceuticals Annual Data
Trend
Forward PE Ratio

Olema Pharmaceuticals Quarterly Data
Forward PE Ratio

OLMA vs DRTS, ORIC, KURA: Forward PE Ratio Comparison

For the Biotechnology subindustry, Olema Pharmaceuticals's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Olema Pharmaceuticals Forward PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Olema Pharmaceuticals's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Olema Pharmaceuticals's Forward PE Ratio falls into.


OLMA
28GF Score
Olema Pharmaceuticals inc OLMA
Forward PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Olema Pharmaceuticals Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Frequently Asked Questions Learn more about Forward PE Ratio →
What does a Forward PE Ratio of 0.00 mean?
Olema Pharmaceuticals (OLMA) has a Forward PE Ratio of 0.00 as of Jul. 08, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Olema Pharmaceuticals and its competitors. According to the industry distribution chart, Olema Pharmaceuticals ranks #999999 out of 354 companies in the Biotechnology industry.
Is Olema Pharmaceuticals' Forward PE Ratio too high?
Olema Pharmaceuticals' current Forward PE Ratio is 0.00. Based on the distribution chart, Olema Pharmaceuticals ranks #999999 out of 354 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Olema Pharmaceuticals has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Olema Pharmaceuticals' Forward PE Ratio compare to DRTS and ORIC?
According to the Biotechnology industry distribution chart, Olema Pharmaceuticals ranks #999999 out of 354 companies for Forward PE Ratio. This places Olema Pharmaceuticals in the lower half of its industry. The industry median Forward PE Ratio is 21.81. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Biotechnology company?
The median Forward PE Ratio among Biotechnology companies is 21.81, based on 354 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Olema Pharmaceuticals and its competitors. For the Biotechnology industry, the median Forward PE Ratio is 21.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Olema Pharmaceuticals's current Forward PE Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olema Pharmaceuticals stock overvalued right now?
Olema Pharmaceuticals (OLMA) has a current Forward PE Ratio of 0.00. The current Forward PE Ratio is 0.00. Olema Pharmaceuticals' overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Olema Pharmaceuticals (OLMA), the current Forward PE Ratio is 0.00 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Olema Pharmaceuticals Business Description

Address 780 Brannan Street, San Francisco, CA, USA, 94103
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
28GF Score

Get the complete analysis for OLMA

Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.28
Price